SIRT1 is a founding member of a sirtuin family of seven proteins and histone deacetylases. It is involved in cellular resistance to stress, metabolism, differentiation, aging, and tumor suppression. SIRT1 -/mice demonstrate embryonic and postnatal development defects. We examined hematopoietic and endothelial cell differentiation of SIRT1 -/mouse embryonic stem cells (ESCs) in vitro, and hematopoietic progenitors in SIRT1 +/+ , +/-, and -/mice. SIRT1 -/-ESCs formed fewer mature blast cell colonies. Replated SIRT1 -/-BL-CFCs demonstrated defective hematopoietic potential. Endothelial cell production was unaltered, but there were defects in formation of a primitive vascular network from SIRT1 -/derived embryoid bodies. Development of primitive and definitive progenitors derived from SIRT1 -/-ESCs were also delayed and/or defective. Differentiation delay/defects were associated with delayed capacity to switch off Oct4, Nanog and Fgf5 expression, decreased β -H1 globin, β -major globin, and Scl gene expression, and reduced activation of Erk1/2. Ectopic expression of SIRT1 rescued SIRT1 -/-ESC differentiation deficiencies. SIRT1 -/yolk sacs manifested fewer primitive erythroid precursors.
Introduction
Mouse embryonic stem cells (ESCs) are pluripotent with capacity for unlimited self-renewal or differentiation into endoderm, ectoderm and mesoderm. Self-renewal behavior in vitro is sustained with leukemia inhibitory factor (LIF). 1 With removal of LIF and in the absence of feeder layer cells, ESCs grow into spheres termed embryoid bodies (EBs) which generate hematopoietic and endothelial progeny recapitulating development of those populations in the yolk sac. 2 Hemangioblasts generate blast colonies in vitro displaying hematopoietic and endothelial potential. 3 The ESC/EB system provides a powerful in vitro model to explore cellular and molecular events that specify lineage choice and hematopoietic commitment.
Sirtuins, or Sir2 family proteins, are conserved from bacteria to humans. 4 Sir2 modulates longevity and aging in yeast, C. elegans, and Drosophila. 5 Mammalian homologs of Sir2 encompass a family of seven proteins (SIRT1-SIRT7), among which SIRT1 is the closest human homolog of the yeast Sir2 protein. 4 
SIRT1 de-acetylates proteins including p53 and FOXO
transcription factors, and plays many key functions including energy metabolism, differentiation, aging and tumor suppression. [6] [7] [8] [9] [10] SIRT1 is expressed at high levels in mouse embryos with the highest SIR2α mRNA expression is embryonic day (E) 4.5 embryos. Although expression is down-regulated during subsequent embryogenesis, high level expression remains detectable at E18. 5. 11 A number of SIRT1 deficient (-/-; knock-out) mouse strains have been developed. Mice carrying a truncation mutation through targeted replacement of exons 5 and 6 with a hygromycin gene demonstrate 50% mortality at an early postnatal stage. 12 Up to 90% of SIRT1 mutant mice carrying a deletion of exon 4 died perinatally, exhibiting developmental defects of retina and heart, the remaining 10% of these mutants still surviving at weaning. [12] [13] [14] In another study, 10 
a
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 4 majority of SIRT1 -/mice died at E9.5-E14.5; about 1% of the mutants on the 129SvEv/FVB background and 9.3% on the 129SvEv/FVB/Black Swiss background survived to adulthood. 10 These studies suggest that SIRT1 is important in embryonic development. Thus, functions of SIRT1 are worth investigating to better understand mammalian embryogenesis.
Endothelial and hematopoietic lineages develop in parallel, and are most intertwined in yolk sac blood islands and the dorsal aorta in the embryo. [15] [16] In both the yolk sac and embryonic dorsal aorta, blood vessels give rise to the hematopoietic elements via specialized hemogenic endothelium. 17 Although SIRT1 regulates vascular endothelial homeostasis controlling angiogenesis, vascular tone and endothelial dysfunction, [18] [19] little information is available on SIRT1 activities in embryonic and adult stages of hematopoietic and endothelial development.
We demonstrated that SIRT1 regulates apoptosis and Nanog expression in mESCs in the presence of LIF and 2ME-withdrawal-induced increase in reactive oxygen species by controlling p53 subcellular localization. 20 Herein, we evaluated the effect of SIRT1 -/on differentiation of mESCs in the presence of 2-ME, but absence of LIF, and report a number of delays and/or defects, especially in hematopoietic development. Hematopoietic progenitor cell defects were also apparent in embryonic yolk sac and young (5 week) and adult (>1 year) bone marrow from SIRT1 -/mice. Differences in growth of hematopoietic progenitor cells from EBs or adult marrow in SIRT1 +/+ and SIRT1 -/cells were much greater and in some cases only apparent when cells were cultured under low (5% O 2 ) oxygen tension compared with normoxia. This demonstrates a role for SIRT1 as a modulator for mouse ESC differentiation, and early and later hematopoietic progenitor cell growth in mice. 
Progenitor cell assays
Primitive erythroid and definitive progenitors generated from mESCs. EBs were digested with 0.25% trypsin (Gibco), passaged through a 20-gauge needle 2-3 times, and plated at 25,000 cells/mL with erythropoietin (EPO; 5U/mL; R&D system, Minneapolis, MN), Stem Cell Factor (SCF; 100ng/mL; R&D system) and Interleukin-3 (IL-3; 1ng/mL; R&D system) for definitive erythroid progenitors, or with EPO (5U/mL), SCF (100ng/mL), IL-3 (1ng/mL), granulocytemacrophage colony-stimulating factor (GM-SCF; 10ng/mL; R&D system), and macrophage colony-stimulating factor (M-CSF; 5ng/mL; R&D system) for multipotential and granulocytemacrophage progenitors. For primitive erythroid progenitors, cells were plated with 15% plasmaderived serum (Animal Technologies, Antech, TX) and Epo (5U/ml). 22 Primitive erythroid yolk sac (E8-E8.25) progenitors. Treatment with 0.25% collagenase (Sigma, St Louis, MO) plus 20% FCS for 10 mintues at 37 ºC with vigorous pipetting resulted in single cells which were plated with 15% plasma-derived serum (Animal Technologies) and Epo (5U/mL). Colonies were counted at day 5. 22 Embryos were generated as described. 10 Adult marrow hematopoietic progenitors. 5×10 4 bone marrow nucleated cells were plated onto 35-mm Petri dishes in methylcellulose with 30% FBS (Hyclone), 1U/ml hu Epo, 5% pokeweed mitogen mouse spleen cell conditioned medium, and 50 ng/ml murine SCF. 23 Colonies were scored after 7 days at ~20% or 5% O 2 . Mating of Mice were conducted as described. 10
Blast colony-forming cell (BL-CFC) assays
EBs were collected at different days post differentiation in liquid culture, washed in PBS, and treated with 0.25% trypsin for 3 minutes at 37ºC. EBs were dissociated into single cells by passage two-three times through a 23-gauge needle, and plated at 3 × 10 4 cells in 1ml of methycellulose medium with 10% FBS, SCF (100ng/mL), 25% D4T endothelial cell-conditioned medium, 24 5 ng/ml mouse Vascular Endothelial Growth Factor (VEGF; R& D system), 10 ng/ml human Interleukin-6 (IL-6; R&D system) and IMDM. Cells were maintained at 37 ºC in a humidified 5% CO 2 incubator under normoxia. After 3-4 days, developing BL-CFCs were counted.
Generation of hematopoietic and endothelial cells from BL-CFCs
Individual BL-CFCs were picked and transferred to Matrigel-coated (BD Biosciences) 96-well plates containing IMDM supplemented with 10% plasma derived serum, 10% horse serum (Invitrogen), transferrin (150µg/mL), VEGF (5 ng/ml), insulin-like growth factor 1 (IGF1, 10 ng/ml; Peprotech), Epo (2U/mL), fibroblast growth factor (bFGF, 10 ng/ml; Peprotech), IL-11
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 7 (50 ng/ml; R&D Systems), SCF (100 ng/ml), L-glutamine (2 mM), and 4.5×10 -4 MTG. After 4 days in culture, non-adherent cells of each well were harvested and cultured in 1mL methycellulose containing the above mixture of cytokines used for growth of hematopoietic progenitors. Adherent cells were cultured an additional 1-2 weeks in IMDM with 10% FCS, 10% horse serum, VEGF (5 ng/ml), IGF-1 (10 ng/ml), bFGF (10 ng/ml), ECGS (100 μ g/ml), Lglutamine (2 mM) and 4.5×10 -4 MTG. 3
Immohistochemistry
Staining for endothelial cells derived from EBs was as described 25 except that we stained for Dil-Ac-LDL (10µg/mL; BD Biosciences) and CD144 (BD Pharmingen antibody).
Vascular sprout formation assay
This assay was performed as described. 26 EBs were scored in blinded fashion according to 4 standard classes based on vascular sprout formation: I, no sprout formation; II, few sprouts; III, many sprouts but no network; and IV, many sprouts with network. 26
Flow cytometry analysis for surface markers
Staining was conducted as described. 27 Analyses were performed with FACSCalibur (Becton Dickinson, Sunnyvale, CA). Monoclonal antibodies used were, ckit-APC (2B8, eBioscience),
and Flk-1-PE (BD Bioscience).
Real-time PCR analysis
An RT 2 Profile Custom PCR Array was used to simultaneously examine mRNA levels of 48 genes, including three "housekeeping genes" in 96-well plates according to the manufacturer For personal use only. on October 3, 2017. by guest www.bloodjournal.org From (SuperArray Bioscience). Real-time PCR was performed on an MX30000P Stratagene machine with SYBR Green PCR Master Mix (Superarray). PCR conditions consisted of a 10 min hot start at 95ºC, followed by 40 cycles of 15 seconds at 95ºC and 1 min at 60ºC. The average threshold cycle for each gene was determined from triplicate reactions and three independent experiments.
Values were exported to a template Excel file for analysis. Analyses of raw data were done through the Superarray Data Analysis Web Portal (http://www.sabiosciences.com/pcr/arrayanalysis.php).
Western blot analysis
Protein extracts from 2×10 6 mESCs were prepared and immunoblots performed according to standard techniques. To determine that amounts of protein in each lane were comparable, the membrane was cut at about the expected molecular weight of target proteins and β -actin. The cut membranes were respectively probed with antibodies against target proteins or a rabbit polyclonal antibody against β -actin.
Statistical Analysis
Significant differences were determined by student t-test comparisons for at least 3 experiments each, with triplicates performed for each experiment.
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Results

Delayed hemangioblast development in absence of SIRT1
To assess whether SIRT1 plays a role in hemangioblast development, the ability of SIRT1 deficient ESCs to give rise to BL-CFCs was tested. BL-CFCs were analyzed on day 3, 3.5, 4, 5, 5.5, 6 and 7 respectively. As shown in Figure 1A Figure 1A ).
To further assess if SIRT1 -/affects in vitro differentiation potential of ESCs we analyzed temporal expression patterns of cell surface Flk1 and c-Kit. Flk1 is the receptor 2 for VEGF (VEGF-R2). Others demonstrated that Flk-1 is expressed on BL-CFCs, and onset of Flk1 corresponds to BL-CFC development. c-Kit is expressed on ESCs and populations found at early stages of EB development; 3, 24 its expression is down-regulated following differentiation. Beyond the hemangioblast stage, c-Kit is co-expressed with Flk1 marking establishment of hematopoiesis. 29 As shown in Figure 1B 
SIRT1-deficient BL-CFCs have reduced hematopoietic, but unaffected endothelial, replating potential
To assess developmental potential of blast colonies, single SIRT1 +/+ and SIRT1 -/-BL-CFCs were replated, transferred to microtiter wells, and cultured for 4 days to determine their potential to generate adherent (endothelial) and nonadherent (hematopoietic) cells. Considering the differing peak of blast colony formation in SIRT1 +/+ and SIRT1 -/-ESCs, day 4 SIRT1 +/+ and day 5.5 SIRT1 -/blast colonies were used respectively. After expansion, nonadherent cells of each well were replated in methycellulose to assay hematopoietic potential. Adherent cells were cultured for an additional week and then harvested and analyzed for expression of genes associated with the endothelial lineage. Endothelial cells express vascular endothelial cadherin (VE-cadherin, CD144) and take up acetylated low-density lipoprotein (Ac-LDL). 25 Colonies from SIRT1 +/+ and SIRT1 -/cells generated both types of cells. Adherent cells derived from SIRT1 +/+ and SIRT1 -/-BL-CFCs, both displayed Dil-Ac-LDL uptake (red) as well as CD144 expression (green) ( Figure  1D ), indicating that adherent populations derived from SIRT1 +/+ and SIRT1 -/individual blast colonies are of the endothelial lineage. Replating revealed that whereas SIRT1 +/+ and SIRT1 -/generated endothelial cells at a similar frequency, the nonadherent populations from SIRT1 -/blast colonies contained fewer secondary hematopoietic precursors with colony-forming potential ( Figure 1E ). Transitional colonies derived from SIRT1 -/-ESCs were also replated and analyzed. They were able to give rise to adherent (endothelial) populations (data not shown).
However, they did not generate round nonadherent (hematopoietic) cells after 4-day culture, which suggests their inability to generate hematopoietic progeny. 
Hematopoietic cell differentiation of SIRT1 -/cells is defective
Deletion of SIRT1 results in defective formation of a vascular-like network in vitro
To assess a role for SIRT1 in angiogenesis, vascular sprout formation developed from day 6 EBs was assessed using a three dimensional spheroidal assay. SIRT1 +/+ and SIRT1 -/-EBs developed similar endothelial outgrowths when embedded into collagen gel ( Figure 3A ). Quantitative analysis on the percentage of angiogenic EBs revealed that loss of SIRT1 expression does not significantly affect endothelial sprout formation ( Figure 3B ). However, SIRT1 -/cells did not form a full vascular-like network in vitro ( Figure 3C ); they had significantly fewer class III (many sprouts but not network) and class IV (abundant networked tubules) vascular sprout formations than SIRT1 +/+ EBs ( Figure 3D ).
SIRT1 deficiency affects expression of genes involved in mESC differentiation and hematopoietic commitment
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Given the inappropriate differentiation and reduced hematopoietic potential of SIRT1 -/-ESCs, we collected RNA from EBs and quantified transcript levels of genes (by quantitative RT-PCR) that might shed light on loss of ESC differentiation potential. This includes genes involved in development of epiblast-like cells, onset of mesoderm development, and markers for other germ layers in EBs at different stages. Expression of Oct4 (Pou5f1) and Nanog, well known pluripotency transcription factors, were rapidly shut down upon differentiation of SIRT1 +/+ cells, consistent with rapid loss of potential to generate secondary EBs. However, down-regulation of Oct4 and Nanog was remarkably delayed in SIRT1 -/cells upon differentiation ( Figure 4A ).
Notably Fgf5, a gene expressed in the epiblast of early embryos and down-regulated after prehemangioblast mesoderm stage 27 was increased and maintained in SIRT1 -/-EBs. Meanwhile, expression of T and Wnt3, indicative of mesoderm commitment and development, was delayed and sustained ( Figure 4B ). These gene expression pattern, combined with the results of blast and transitional colony formation in SIRT1 -/-EBs, indicates the earliest stages of hemangioblast commitment are occurring, but not fully developed in SIRT1 -/-ESCs at the appropriate time points. We further analyzed expression of Scl/Tal-1, a transcription factor essential for commitment of mesoderm to hematopoiesis 28 . It was delayed at least 24 hours and greatly decreased on days 4, 6, and 8 in SIRT1 -/-EBs ( Figure 4B ), which is consistent with the interpretation that progression of hematopoietic commitment was compromised in SIRT1 -/cultures. Trophectoderm marker Cdx2 ( Figure 4B ), and molecular markers for endoderm/mesoderm GATA-4, Sox17, and GATA-6 showed delayed expression in SIRT1 -/cells, but at later days, there was no difference between the expression of these genes in SIRT1 +/+ and SIRT1 -/-EBs ( Figure 4C ). Expression of a gene for cardiac lineage marker Nkx2.5 showed no difference. In addition, the hematopoietic-specific gene GATA-1 was reduced in day 5 SIRT1 -/- EBs. Notably, GATA-1 at late stage and Runx-1 were non-significantly decreased ( Figure S2A,   B ), suggesting that SIRT1 may largely affect early stages of ES cell commitment to hematopoietic lineage. Together, these data suggest that SIRT1 is critically involved in gene expression for early commitment and differentiation.
Aberrant signaling pathways during differentiation of SIRT1 -/-ESCs
Activation of the Ras-Raf-Mek-Erk signaling cascade is important for morphology and gene expression changes indicative of early ES cell differentiation by LIF withdrawal. 31 When the Erk pathway is inhibited in LIF withdrawn cells, the pluripotent marker Oct4 shows delayed downregulation. 31 SIRT1 inhibition reduces Erk1/2 signaling in cultured neurons, 32 so we assessed whether delay in loss of pluripotency markers in SIRT1 -/-EBs is associated with effects on the Erk pathway during SIRT1 -/-ESC commitment. Phosphorylated Erk1/2 was gradually increased during early SIRT1 +/+ ESC differentiation, consistent with a previous report. 31 However, Erk phosphorylation was greatly impaired in SIRT1 -/cells ( Figure 5A, B) . To evaluate signaling pathways for mesodermal differentiation within EBs, high-throughput mRNA expression profiling was used to examine gene expression involved in bone morphogenetic protein (BMP), fibroblast growth factor (FGF) and Wnt pathways. Expression of Bmpr, smad8, and smad3 was delayed in SIRT1 -/compared with SIRT1 +/+ EBs. Smads are intracellular signal transducers of the BMP pathway. Among them, Smad7 is an inhibitory molecule for the BMP-SMAD pathway. 33 Smad7 inhibits mesoderm formation and promotes neural cell fate in Xenopus embryos. 34 Of note, Smad7 was persistently expressed at higher levels in SIRT1 -/than in SIRT1 +/+ EBs ( Figure 5C ). This is interesting in light of Smad 7 down-regulation by SIRT1. 35 Expression of several components of FGF and Wnt signal transduction pathways were altered in SIRT1 -/-EBs (Figure S2 A, B ). FGF and Wnt pathways are implicated in hematopoietic Figure 6B ). SIRT1 -/cells generated few EryP on day 4.5, but numbers of primitive progenitors in SIRT1 -/cells was significantly increased with reconstitution of SIRT1 to a level comparable to SIRT1 +/+ cells ( Figure 6C ). Also, expression of hemoglobin genes, Hbb-bh1 ( Figure 6D ) and Hbb-b1 ( Figure 6E ) was recovered in SIRT1-/-cells with the SIRT1 gene insert vector, compared with SIRT1 +/+ cells. This demonstrates that the altered hematopoietic differentiation potential observed for SIRT1 -/cells was specific to deletion of SIRT1.
Defective primitive hematopoiesis during early development, and decreased adult hematopoiesis in SIRT1 -/mice
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Based on our above studies we evaluated embryo and adult bone marrow hematopoiesis in SIRT1 +/+ , SIRT1 +/and SIRT1 -/mice. 10 We performed in vitro colony-forming assays on yolk sac cells from E8 to E8.25 embryos. We observed significant decreases in absolute numbers of primitive erythroid progenitors from SIRT1 -/-, but not SIRT1 +/-, E8 to E8.25 yolk sacs under normoxic conditions compared to +/+ yolk sacs ( Figure 7A ). Genotypes of the yolk sacs were confirmed ( Figure 7B ). Less than 10% of SIRT1 -/mice survive to birth, 10 but SIRT1 +/mice are born with normal Mendelian genetics. We assessed absolute numbers of hematopoietic progenitor cells (CFU-GM, BFU-E, and CFU-GEMM) per femur of 5 week old SIRT1 +/vs.
SIRT1 +/+ mice detected via culturing bone marrow cells in vitro at both ~20% and 5% O 2 tension.
In that way, we could determine if there were differences in progenitor cell numbers in the +/and +/+ cells, and whether or not the growth of these cells could be enhanced by growth in lowered O 2 . While we detected no significant differences in colony numbers of +/+ and +/-cells grown in vitro under normoxic conditions from bone marrow of 5 week old mice, we found that +/+, but not +/-cells were enhanced in numbers at lowered O 2 ( Figure 7C ). Thus, +/-cells do not sense enhanced growth conditions of lowered O 2 . We were also able to evaluate SIRT1 +/+, +/and -/-mice that were over one year old. As shown in Figure 7D , absolute numbers of SIRT1 +/and SIRT1 -/progenitors were significantly decreased by almost half when cells were cultured under normoxic conditions, suggesting an age-related decrease in SIRT +/numbers. Consistent with the SIRT1 +/data from 5 week old mice ( Figure 7C ), neither SIRT1 +/nor SIRT1 -/progenitors from the more aged mice responded to the enhancing effects of lowered O 2 that the SIRT1 +/+ cells responded to, confirming that SIRT1 +/-, and also SIRT1 -/progenitors from adult bone marrow fail to respond to lowered O 2 . At lowered O 2 , the differences detected in numbers of progenitor cells in S-phase from +/+ mice to that of either SIRT1 +/or SIRT1 -/-, was
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From substantially greater than that seen at normoxia ( Figure 7E ). Nucleated bone marrow cellularities/femur did not show significant differences between SIRT1 +/+, +/-, or -/-mice (Supplemental Table 1 ). We also assessed the in vitro survival of hematopoetic progenitor cells (CFU-GM) from 5 week and over 1 year old mice growing at 5% O 2 in response to growth factor deprivation and delayed addition of Epo, PWMSCM and TPO at day 1 after culture in the presence of FBS. Seven days after addition of cytokines there was a significantly greater decrease in colony formation for 5 week old bone marrow of +/-mice and -/-marrow of >1 year old mice compared to their comparable aged matched +/+ mice ( Figure 7F ). This demonstrates that SIRT1 +/-and -/-progenitors survive less well than the +/+ progenitors, under these conditions of growth factor deprivation. Also, there was a significantly greater decrease in progenitor cells from older compared to younger +/+ mice. Figure   S3 ), indicating that in unperturbed conditions, SIRT1 is not required to maintain the undifferentiated phenotype state. This concurs with previous findings 12 and studies suggesting that elimination of SIRT1 in mouse TC1 ESCs has little impact on expression of pluripotency factors. 40 However, consistent with the latter work 40 indicating SIRT1 regulation of Wnt signaling pathways. 42 The Erk pathway is involved in ESC differentiation. As noted, phosphorylation of Erk is less activated in SIRT1 -/cells. An inhibitory Smad for BMP signaling, Smad7, is persistently expressed in SIRT1 -/-EBs. Smad7 is involved in early patterning events.
Low levels of Smad7 block activation of dorsal mesoderm genes, and high levels block all mesoderm gene expression in Xenopus embryos. 34 In mesangial cells, SIRT1 interacts with Smad7. Smad7 expression level was increased by SIRT1 knock-down. 35 Persistent expression of Smad7 in SIRT1 -/-EBs may account for defective differentiation in SIRT1 -/-EBs.
Evidence from mouse models indicates that SIRT1 is a central regulator of embryonic and somatic stem cell function. 20, 43 We found that lack of SIRT1 expression led to decreases in primitive erythroid progenitor cells in E8 to E8.25 yolk sacs. Since the majority of SIRT1 null embryos die between E9.5 and E14.5, we did not have access to SIRT1 -/embryos at later time points. We cannot exclude the possibility that decreased Ery-P is because there is a developmental delay in SIRT1 -/embryos. Consistent with studies of Wang et al, 10 SIRT1 -/embryos were abnormally small. In addition, these embryos show nuclear fragmentation and cell death. This could be another reason for differences in numbers of Ery-P in SIRT1 -/embryos.
Analysis of bone marrow of SIRT1 -/adult mice demonstrated decreased hematopoietic
progenitor cell numbers and cell cycle status. The decrease was more apparent when cells were cultured under lowered O 2 tension. This is of interest since during hypoxia, activated SIRT1 augments HIF-2α signaling and consequently participates in regulation of the HIF-2α target gene, Epo. 44 Congenital SIRT1 deficiency affects fetal and adult Epo gene expression in mice. 44 Epo, generally considered an erythropoietic growth factor, is also a potent prosurvival factor that protects developing stem and progenitor cells in a variety of organs. 45 Renal Epo gene expression differs between SIRT1 +/and SIRT1 +/+ mice exposed to 6% O 2 , while both groups of mice have similar amounts of renal Epo mRNA under ambient O 2 44 . Similarly, our data showed that hematopoietic progenitor colony formation from adult mice significantly differed between SIRT1 +/+ and SIRT1 +/mice under 5% O 2 while both groups of mice had similar numbers under normoxia. We also found that hematopoietic progenitor cells from SIRT1 +/+ and SIRT1 -/mice survive less well in vitro at lowered O 2 tension after the stress of delayed addition of growth factors. Decreased survival is directly associated with enhanced apoptosis. 46 Sirtuins are implicated in aging. 47 SIRT1 +/mice are born with apparently normal mendelian genetics, while less than 10% of SIRT1 -/mice live to birth. It is not yet clear why some SIRT1 -/mice live to birth while others don't. We detected no significant differences in primitive erythroid progenitors generated between SIRT1 +/and SIRT1 -/embryos, similar to HPC numbers from 5
week old SIRT1 +/and SIRT1 +/+ mice when cells were cultured under normoxia. That SIRT1 +/cells from adult mice (>12 months) demonstrate decreased hematopoietic progenitor cell numbers at normoxia, similar to that of SIRT1 -/cells and that SIRT1 +/and SIRT1 -/cells in the aged mice show even greater differences compared with SIRT1 +/+ mice when cells are cultured at lowered O 2 allows us to evaluate a role for SIRT1 in the hematopoietic aging process, as there will be more SIRT1 +/than SIRT1 -/mice surviving to older ages.
Analyses of SIRT1 -/mice revealed that this protein serves essential functions during embryonic and postnatal development, as well as for several homeostatic programs during adulthood. [12] [13] [14] 48 Our results demonstrate that SIRT1 is an important regulator of mESC differentiation and hematopoiesis, and suggest its role in the earliest stages of hematopoietic and endothelial development. Since hematopoietic and endothelial development is not extinguished by knock-out of SIRT1 but rather is delayed, and definitive hematopoiesis is less affected compared with primitive hematopoiesis, there might be distinct pathways of differentiation for primitive and (A)Primitive erythroid colony formation from yolk sac (YS) cells generated from E8 to E8.25
